Promo16 Juli 2024
Kalbe to spend $149m on business expansion
The company would build new factories for nutritional products later in the second quarter in Cikampek and Sukabumi
Bareksa•16 Mei 2014
Bareksa•16 Mei 2014
The company would build new factories for nutritional products later in the second quarter in Cikampek and Sukabumi
The Jakarta Post - The country’s largest drug maker, PT Kalbe Farma, has set aside up to Rp 1.7 trillion (US$149.4 million) of its internal cash for business expansion this year.
Kalbe external communications manager Hari Nugroho said after a shareholders meeting on Wednesday that the company would spend between Rp 1 trillion and 1.2 trillion on capital expenditure to boost its production capacity and expand distribution channels.
Promo Terbaru di Bareksa
Pilihan Investasi di Bareksa
Klik produk untuk lihat lebih detail.
| Produk Eksklusif | Harga/Unit | 1 Bulan | 6 Bulan | YTD | 1 Tahun | 3 Tahun | 5 Tahun |
|---|---|---|---|---|---|---|---|
Trimegah Dana Tetap Syariah | 1.337,76 |  0,49% | 3,72% | 0,04% | 4,75% | 18,40% | - |
Capital Fixed Income Fund | 1.793,05 | 0,56% | 3,35% | 0,04% | 6,95% | 16,60% | 40,13% |
I-Hajj Syariah Fund | 4.872,25 | 0,59% | 3,20% | 0,03% | 6,16% | 22,01% | 40,68% |
STAR Stable Amanah Sukuk Produk baru | 1.047,73 | 0,53% | 3,64% | 0,04% | - | - | - |
Reksa Dana Syariah Syailendra OVO Bareksa Tunai Likuid | 1.147 | 0,31% | 2,63% | 0,03% | 4,97% | 14,27% | - |
Produk Belum Tersedia
Ayo daftar Bareksa SBN sekarang untuk bertransaksi ketika periode pembelian dibuka.
Produk Belum Tersedia
Ayo daftar Bareksa SBN sekarang untuk bertransaksi ketika periode pembelian dibuka.
Video Pilihan
Lihat SemuaArtikel Lainnya
Lihat SemuaBerita Ekonomi Terkini25 Juli 2014
Berita Ekonomi Terkini16 Juli 2014
Berita Ekonomi Terkini17 Juni 2014
Berita Ekonomi Terkini21 Maret 2014
SBN09 Juli 2024
SBN12 Juli 2024
Reksa Dana12 Juli 2024
Reksa Dana09 Juli 2024